thiophenes has been researched along with thromboxanes in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (36.36) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adolphson, RL; Conroy, MC; Schellenberg, RR; Thueson, DO | 1 |
| Asai, F; Ito, T; Matsuda, K; Oshima, T; Ushiyama, S | 1 |
| Darius, H; Ferber, H; Schrör, K; Smith, EF | 1 |
| Gragnoli, G; Signorini, AM; Tanganelli, I | 1 |
| d'Avenia, V; di Minno, G; Iovine, C; Mattioli, PL; Turco, S | 1 |
| Kuhn, A; Sauerland, S; Schiffer, K; Schrör, K | 1 |
| Asai, F; Matsuda, K; Nakagawa, A; Oshima, T; Sugidachi, A; Takasaki, W; Tanaka, Y; Ushiyama, S | 1 |
| Bhavaraju, K; Gartner, TK; Georgakis, A; Jin, J; Kunapuli, SP; Nurden, A; Nurden, P; Tomiyama, Y | 1 |
| Dhanji, AR; Kirkby, NS; Leadbeater, PD; Milne, GL; Mitchell, JA; Thomas, S; Tucker, AT; Warner, TD | 1 |
| Bray, P; Dangelmaier, C; Jin, J; Kunapuli, SP; Liverani, E; Manne, BK | 1 |
| Badolia, R; Borst, O; Campbell, RA; Kunapuli, SP; Manne, BK; Middleton, E; Münzer, P; Rondina, MT; Walker-Allgaier, B; Weyrich, AS | 1 |
1 trial(s) available for thiophenes and thromboxanes
| Article | Year |
|---|---|
Antagonism of P2Y₁₂ reduces physiological thromboxane levels.
Topics: Adenosine Diphosphate; Adolescent; Adult; Animals; Blood Platelets; Clopidogrel; Female; Humans; Male; Mice; Mice, Knockout; Middle Aged; Pilot Projects; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Thiophenes; Thromboxanes; Ticlopidine; Young Adult | 2010 |
10 other study(ies) available for thiophenes and thromboxanes
| Article | Year |
|---|---|
CI-959, a new, potential antiallergic drug, inhibits mediator release from lung and contractions of human airways in vitro.
Topics: Animals; Bronchoconstriction; Dose-Response Relationship, Drug; Guinea Pigs; Histamine Antagonists; Histamine Release; Humans; Immunoglobulin E; Leukotrienes; Lung; Tetrazoles; Thiophenes; Thromboxanes | 1990 |
In vitro antiplatelet profiles of the new thromboxane synthetase inhibitor sodium 2-(1-imidazolylmethyl)-4,5-dihydrobenzo[b]thiophene-6-carboxylate.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Animals; Aspirin; Dogs; Humans; Imidazoles; In Vitro Techniques; Male; Methacrylates; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Thiophenes; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes | 1991 |
Inhibition of thromboxane and 12-HPETE formation by dazoxiben and its two thiophenic acid-substituted derivatives.
Topics: Animals; Arachidonic Acids; Blood Platelets; Cattle; Epoprostenol; Humans; Imidazoles; In Vitro Techniques; Leukotrienes; Oxidoreductases; Platelet Aggregation; Rabbits; Thiophenes; Thromboxane-A Synthase; Thromboxanes; Vasoconstriction | 1985 |
[Effects of ticlopidine on the plasma levels of beta-thromboglobulin and thromboxane B2 in types 1 and 2 diabetics].
Topics: Beta-Globulins; beta-Thromboglobulin; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Thiophenes; Thromboxane B2; Thromboxanes; Ticlopidine | 1984 |
Ex vivo effects of ticlopidine on human platelets: inhibition of fibrinogen binding by a mechanism independent of thromboxane formation.
Topics: Anticoagulants; Blood Platelets; Fibrinogen; Humans; Platelet Aggregation; Thiophenes; Thromboxanes; Ticlopidine | 1984 |
The action of non-steroidal antiinflammatory agents on platelet aggregation and vessel tone in relation to inhibition of PGI2- and thromboxane-release. With particular reference to 5-benzoyl-alpha-methyl-2-thiophene acetic acid (tiaprofenic acid).
Topics: Animals; Anti-Inflammatory Agents; Cattle; Coronary Vessels; Epoprostenol; Guinea Pigs; Heart; In Vitro Techniques; Muscle Tonus; Muscle, Smooth, Vascular; Myocardium; Oxygen Consumption; Platelet Aggregation; Propionates; Prostaglandins; Rabbits; Thiophenes; Thromboxanes | 1980 |
Superiority of plasma 11-dehydro-TXB2 to TXB2 as an index of in vivo TX formation in rabbits after dosing of CS-518, a TX synthase inhibitor.
Topics: Animals; Arachidonic Acid; Eicosanoids; Immunoenzyme Techniques; Infusions, Intravenous; Male; Rabbits; Radioimmunoassay; Thiophenes; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes | 1993 |
Aspirin has little additional anti-platelet effect in healthy volunteers receiving prasugrel.
Topics: Adolescent; Adult; Aspirin; Humans; Male; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Thiophenes; Thromboxanes | 2011 |
PDK1 selectively phosphorylates Thr(308) on Akt and contributes to human platelet functional responses.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; Adaptor Proteins, Signal Transducing; Adenosine Triphosphate; Blood Platelets; Cells, Cultured; Clot Retraction; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Oncogene Protein v-akt; Phosphorylation; Platelet Activation; Pyrimidines; Receptors, Thrombin; Serine; Signal Transduction; Thiophenes; Threonine; Thromboxanes | 2014 |
PDK1 governs thromboxane generation and thrombosis in platelets by regulating activation of Raf1 in the MAPK pathway.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; Animals; Blood Platelets; Disease Models, Animal; Humans; Mice, Knockout; Mitogen-Activated Protein Kinases; Phosphorylation; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Kinase Inhibitors; Proto-Oncogene Mas; Proto-Oncogene Proteins c-raf; Pulmonary Embolism; Pyrimidines; Signal Transduction; Thiophenes; Thrombosis; Thromboxanes | 2018 |